You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

GSK and Pfizer Merging Consumer Health Businesses

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 780 Words

GALWAY, IRELAND--January 14, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) and Pfizer (NYSE:PFE) (New York, New York) have announced plans to merge their consumer healthcare divisions with combined sales of approximately 9.8 billion ($12.7 billion).

Within this article: Details proposed merger, value, product lines affected, impact on manufacturing and jobs

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00